Esto es normal para la mayora de las personas y estos sntomas suelen desaparecer en las primeras semanas
CVS partnering with Novo Nordisk CVS this month announced it was partnering with Novo Nordisk to increase access to Wegovy for its members at more affordable prices
[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Rehfeld JF
These effects are typically mild to moderate, transient, and significantly reduced by starting at a low dose and titrating gradually
Everything in Protocol 1, plus: Protein supplement: Increase to 1.6-2.0 g/kg total daily protein (likely requires 40-80 grams from supplements) Creatine monohydrate: 5 grams daily HMB: 3 grams daily Omega-3 fish oil: 1-2 grams EPA/DHA daily Expected benefits: Significantly reduced lean mass loss, maintained or improved strength, better metabolic rate preservation, improved body composition outcomes

Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users